Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  3. Research Domains
  5. Biomedical And Clinical Sciences
  7. Oncology And Carcinogenesis
  9. Predictive And Prognostic Markers
  11. Serum Tlr2 And Tlr9 In Prostate Cancer Patients In Relation To Ebv Status

Serum TLR2 and TLR9 in Prostate Cancer Patients in Relation to EBV Status

Dominika Sikora1, Jacek Kiś2, Ewa Stępień1

  • 1Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, 20-093 Lublin, Poland.

International Journal of Molecular Sciences
|August 29, 2024

Related Experiment Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

3.8K
In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells
11:56

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells

Published on: May 15, 2014

9.1K

View abstract on PubMed

Summary
This summary is machine-generated.

Higher levels of Toll-like receptors (TLRs), specifically TLR-2 and TLR-9, are linked to advanced prostate cancer (PCa). This research explores the complex role of Epstein-Barr virus (EBV) in PCa development and progression.

Area of Science:

  • Immunology
  • Oncology
  • Virology

Background:

  • Prostate cancer (PCa) development is complex, with Epstein-Barr virus (EBV) infection implicated as a potential predisposing factor.
  • Toll-like receptors (TLRs) play a role in immune responses and cancer, but their specific relationship with PCa, especially in the context of EBV, requires further investigation.

Purpose of the Study:

  • To investigate the association between Toll-like receptor (TLR) levels and prostate cancer (PCa).
  • To explore the potential impact of Epstein-Barr virus (EBV) infection on PCa progression and its correlation with TLRs.

Main Methods:

  • Serum samples from PCa patients were analyzed for levels of selected Toll-like receptors (TLRs).
  • Patients were categorized based on EBV positivity, Gleason score (GS), and T-trait to assess disease severity.
Keywords:
Epstein–Barr virusTLR-2TLR-9prostate cancer

Related Experiment Videos

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
13:19

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

16.5K
Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

3.8K
In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells
11:56

In vitro Method to Observe E-selectin-mediated Interactions Between Prostate Circulating Tumor Cells Derived From Patients and Human Endothelial Cells

Published on: May 15, 2014

9.1K
  • Correlations between TLR levels and antibody titers were examined.

    • Main Results:

    • Elevated serum levels of TLR-2 and TLR-9 were significantly associated with more advanced stages of prostate cancer (PCa).
    • The study identified specific patterns in TLR and antibody levels related to EBV status and disease progression.

    Conclusions:

    • Toll-like receptors (TLRs), particularly TLR-2 and TLR-9, may serve as potential biomarkers for advanced prostate cancer (PCa).
    • Understanding the interplay between viral infections like EBV and the innate immune system via TLRs offers insights into PCa pathogenesis.
    • These findings could inform future diagnostic, preventive, and therapeutic strategies for PCa, especially in EBV-associated cases.